Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Research, Drug Development & Manufacturing
Pharmaceutical ManufacturingPsychedelic-Focused Manufacturers
Research, Drug Development & Manufacturing

Cortexa

Australian psychedelic medicines supply and commercialization venture focused on GMP-grade MDMA and psilocybin pathways for clinical and authorized-prescriber use.

Manufacturing Snapshot

Psychedelic-Focused Manufacturer

Scope & Capabilities

Drug Product ManufacturingAPI ProductionControlled Substance LogisticsRegulatory / CMC Support

Supply Use Cases

Authorized Medical AccessClinical TrialsCommercial / Licensed Supply

GxP / Compliance

GMPGeneral GxP

Facilities & Access

Melbourne-based operational footprint for Australian market supply, with local manufacturing partnerships and distribution channels.

Manufacturing Details

Supported Substances

Cortexa communications describe GMP psilocybin supply under the Australian Authorized Prescriber pathway and domestic GMP MDMA manufacturing scale-up.

Manufacturing Sources

Cortexa (Australia)

https://www.cortexa.com.au/

Cortexa First Supply of Psilocybin Under TGA Authorized Prescriber Scheme

https://pharmala.ca/media/2024/03/cortexa-leads-the-world-in-first-supply-of-psilocybin-under-the-tgas-authorized-prescriber-scheme

Cortexa Commences Manufacturing GMP LaNeo MDMA in Australia

https://pharmala.ca/media/2024/04/cortexa-commences-manufacturing-gmp-laneo-mdma-in-australia

Quick Facts

Website
Visit